{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:32:50Z","timestamp":1767835970252,"version":"3.49.0"},"reference-count":29,"publisher":"Oceanside Publications Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Cephalosporins are beta-lactam antibiotics commonly used in children and are the second most common cause of drug hypersensitivity reactions after penicillins. Antibiotic allergy is diagnosed by tests such as prick and intradermal skin tests and the drug provocation\n test (DPT). Skin tests can be challenging for both patients and clinicians. In appropriate cases, omitting these tests in favour of direct DPT may help to avoid diagnostic delays.  <jats:bold>Objective:<\/jats:bold> Our study aimed to evaluate the results of direct DPT in children with a history\n of mild cutaneous reactions to cephalosporins.  <jats:bold>Methods:<\/jats:bold> Between 2019 and 2024, pediatric patients with a documented history of mild cutaneous reactions to cephalosporins who underwent direct DPT without prior prick or intradermal skin testing were included in this study\n conducted at our clinic. Patients with systemic manifestations beyond cutaneous reactions at the time of the index reaction were excluded from the study.  <jats:bold>Results:<\/jats:bold> The study included 128 patients who underwent direct DPT with cephalosporins. The most commonly suspected drugs\n were cefixime (45.3%), cefdinir (25.8%) and cefuroxime (18%). While 96.1% did not react, cephalosporin allergy was confirmed in 3.9% but all reactions were limited to skin involvement and none more severe than the index reaction.  <jats:bold>Conclusion:<\/jats:bold> In our study, direct DPT ruled\n out suspected allergy in 96.1% of patients with a history of mild skin reactions to cephalosporins. In conclusion, direct oral DPT was found to be a safe and feasible approach for patients with isolated mild skin reactions, effectively bypassing the need for skin testing.<\/jats:p>","DOI":"10.2500\/aap.2025.46.250011","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:32:27Z","timestamp":1747441947000},"page":"235-239","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children"],"prefix":"10.2500","volume":"46","author":[{"given":"Fatma Nur","family":"Kuzucu","sequence":"first","affiliation":[{"name":"From the Department of Pediatric Allergy\/Immunology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cankat","family":"Genis","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy\/Immunology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Selmanoglu","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy\/Immunology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezban","family":"Ipek Demir","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy\/Immunology, Etlik City Hospital, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeynep","family":"Sengul Emeksiz","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy\/Immunology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Dibek Misirlioglu","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Allergy\/Immunology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Turkey and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","article-title":"\u03b2-Lactams and \u03b2-lactamase inhibitors: an overview","volume":"6","author":"Bush","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"295","key":"B2","first-page":"3","article-title":"Penicillin as a chemotherapeutic agent. 1940","author":"Chain","year":"1993","journal-title":"Clin Orthop Relat Res"},{"key":"B3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1469-0691.2000.tb02050.x","article-title":"New oral cephalosporins in pediatric community-acquired infections","volume":"6","author":"Adam","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","article-title":"Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012","volume":"176","author":"Baggs","year":"2016","journal-title":"JAMA Intern Med"},{"key":"B5","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/all.13721","article-title":"A EAACI drug allergy interest group survey on how European allergy specialists deal with \u03b2-lactam allergy","volume":"74","author":"Torres","year":"2019","journal-title":"Allergy"},{"key":"B6","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaip.2017.06.017","article-title":"The 3 Cs of antibiotic allergy\u2014classification, cross-reactivity, and collaboration","volume":"5","author":"Trubiano","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.14122","article-title":"Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper","volume":"75","author":"Romano","year":"2020","journal-title":"Allergy"},{"key":"B9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11882-024-01171-9","article-title":"Cephalosporin allergy: updates on diagnostic testing","volume":"24","author":"Chow","year":"2024","journal-title":"Curr Allergy Asthma Rep"},{"key":"B10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-019-0854-6","article-title":"Evaluating penicillin allergies without skin testing","volume":"19","author":"Banks","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"B11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.anai.2023.01.034","article-title":"Delabeling penicillin allergy in a pediatric primary care clinic","volume":"130","author":"Chow","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40267-024-01051-2","article-title":"Multisite primary care led amoxicillin challenge pathway to safely remove penicillin allergy label","volume":"40","author":"Mari","year":"2024","journal-title":"Drugs Ther Perspect"},{"key":"B13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2020.0403","article-title":"Development and validation of a penicillin allergy clinical decision rule","volume":"180","author":"Trubiano","year":"2020","journal-title":"JAMA Intern Med"},{"key":"B14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaip.2023.10.009","article-title":"Assessing pediatric cephalosporin allergic reactions through direct graded oral challenges","volume":"12","author":"Sillcox","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"B17","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/pai.13529","article-title":"An EAACI Task Force report on allergy to beta-lactams in children: clinical entities and diagnostic procedures","volume":"32","author":"Blanca-Lopez","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"e13745","DOI":"10.1111\/pai.13745","article-title":"New diagnost\u0131c perspectives in the management of pediatr\u0131c beta-lactam allergy","volume":"33","author":"Ar\u0131ko\u011flu","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/all.13037","article-title":"Optimal step doses for drug provocation tests to prove beta\u2010lactam hypersensitivity","volume":"72","author":"Chiriac","year":"2017","journal-title":"Allergy"},{"key":"B20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"B21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fimmu.2014.00393","article-title":"Unbalanced neonatal CD4+ T-cell immunity","volume":"5","author":"Debock","year":"2014","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/all.13848","article-title":"The challenge of de\u2010labeling penicillin allergy","volume":"75","author":"Stone","year":"2020","journal-title":"Allergy"},{"key":"B23","first-page":"460","article-title":"Penicillin allergy delabeling can decrease antibiotic resistance, reduce costs, and optimize patient outcomes","volume":"37","author":"Lee","year":"2020","journal-title":"Fed Pract"},{"key":"B24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1399-3038.2011.01169.x","article-title":"Allergy to betalactam antibiotics in children: results of a 20\u2010year study based on clinical history, skin and challenge tests","volume":"22","author":"Ponvert","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.15996","article-title":"EAACI\/ENDA position paper on drug provocation testing","volume":"79","author":"Barbaud","year":"2024","journal-title":"Allergy"},{"key":"B26","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1016\/j.jaip.2021.04.073","article-title":"Direct challenges for the evaluation of beta-lactam allergy: evidence and conditions for not performing skin testing","volume":"9","author":"Iammatteo","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B27","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1111\/all.14800","article-title":"Single\u2010dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non\u2010immediate reactions to beta\u2010lactams","volume":"76","author":"Prieto","year":"2021","journal-title":"Allergy"},{"key":"B28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jaip.2020.07.056","article-title":"Testing strategies and predictors for evaluating immediate and delayed reactions to cephalosporins","volume":"9","author":"Stone","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/pai.12826","article-title":"Non\u2010immediate\u2010reading skin tests and prolonged challenges in non\u2010immediate hypersensitivity to beta\u2010lactams in children","volume":"29","author":"Lezmi","year":"2018","journal-title":"Pediatr Allergy Immunol"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2025\/00000046\/00000003\/art00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:32:18Z","timestamp":1761021138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2025.46.250011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5,1]]}},"alternative-id":["1088-5412(20250501)46:3L.235;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2025.46.250011","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}